Skip to main content
Coronavirus (COVID-19): Latest updates.


1st Mini Symposium for the Cancer Genetics Biomedical Research Unit

25 April 2012

Today is the first meeting of the Cancer Genetics Biomedical Research Unit. The Biomedical Research Unit is a NISCHR funded research group which aims to translate new genetic knowledge for better prevention, diagnosis and treatment of cancer. It includes researchers from Bangor and Cardiff.

As part of a brief introduction to the projects within the BRU, Duncan Baird and Kate Liddiard talked about measuring telomeres for cancer prognosis. They showed exciting evidence that telomere length has a strong prognostic value in cancer, including CLL. This project builds on the novel assays developed by the Telomere group including STELA and assays of chromosome fusions. These have been applied to samples from CLL patients and other systems.



Leave a reply

Your email address will not be published. Required fields are marked *